GW Henssler & Associates Ltd. Decreases Stake in Aetna Inc. (AET)
GW Henssler & Associates Ltd. reduced its stake in Aetna Inc. (NYSE:AET) by 9.9% during the second quarter, according to its most recent filing with the SEC. The fund owned 18,476 shares of the company’s stock after selling 2,034 shares during the period. GW Henssler & Associates Ltd.’s holdings in Aetna were worth $2,805,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in AET. Parametrica Management Ltd acquired a new stake in shares of Aetna during the first quarter valued at $212,000. Fox Run Management L.L.C. boosted its stake in shares of Aetna by 31.8% in the first quarter. Fox Run Management L.L.C. now owns 2,900 shares of the company’s stock valued at $370,000 after buying an additional 700 shares in the last quarter. Reilly Financial Advisors LLC boosted its stake in shares of Aetna by 1.8% in the first quarter. Reilly Financial Advisors LLC now owns 77,085 shares of the company’s stock valued at $9,832,000 after buying an additional 1,370 shares in the last quarter. Vicus Capital acquired a new stake in shares of Aetna during the first quarter valued at $203,000. Finally, Telemus Capital LLC boosted its stake in shares of Aetna by 11.8% in the first quarter. Telemus Capital LLC now owns 7,739 shares of the company’s stock valued at $987,000 after buying an additional 817 shares in the last quarter. Institutional investors own 91.69% of the company’s stock.
Shares of Aetna Inc. (AET) opened at 155.90 on Thursday. The stock has a market capitalization of $51.77 billion, a price-to-earnings ratio of 34.61 and a beta of 0.54. The stock’s 50 day moving average is $154.63 and its 200-day moving average is $139.99. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69.
Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company’s quarterly revenue was down 2.7% on a year-over-year basis. During the same period last year, the company earned $2.21 EPS. On average, analysts anticipate that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio (DPR) is 43.67%.
WARNING: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/17/gw-henssler-associates-ltd-decreases-stake-in-aetna-inc-aet.html.
Several equities research analysts recently weighed in on AET shares. Royal Bank Of Canada restated a “buy” rating and issued a $145.00 price target on shares of Aetna in a research report on Monday, April 24th. Cantor Fitzgerald restated an “overweight” rating and issued a $150.00 price target (up previously from $140.00) on shares of Aetna in a research report on Wednesday, May 3rd. Stifel Nicolaus restated a “buy” rating and issued a $150.00 price target (up previously from $130.00) on shares of Aetna in a research report on Wednesday, May 3rd. Jefferies Group LLC restated a “hold” rating and issued a $140.00 price target (up previously from $133.00) on shares of Aetna in a research report on Wednesday, May 3rd. Finally, Cleveland Research upgraded shares of Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Eight analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Aetna has an average rating of “Buy” and an average price target of $157.09.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.